Peli Continues Enhancement of Cold Chain Industry
News Apr 23, 2013
Peli Products, Inc. has announced the acquisition of Minnesota Thermal Science (MTS), the industry leader in global temperature controlled transportation products.
Based in Plymouth, Minnesota, MTS will merge with Peli’s already established BioPharma™ division.
“The combined entity will offer customers an even wider range of the most advanced temperature controlled packaging solutions for the safe transport of pharmaceuticals, tissue, biologics, diagnostics, blood and other healthcare products,” said Lyndon Faulkner, President and CEO of Peli.
Faulkner continued, “The award-winning thermal protection products of MTS will be matched with Peli’s global capabilities providing a worldwide solution of re-usable transportation and packaging products and services.”
In addition to Peli BioPharma cases that offer 140+ hours between 2.0 to 8.0C, customers will have access to the full suite of MTS products including the reusable Credo Cube®, which protects payload contents at defined temperatures longer than any other passive thermal shipper.
Equally impressive are the Credo Xtreme® full pallet which holds 890 litres and the half pallet which holds 406 litres, each providing 35 percent more payload space than the closest competitor.
In addition to their unique scientific packaging, MTS offers a complete range of services and software to support a reusable temperature controlled packaging solution.
“Joining forces with Peli will enable us to aim even higher and provide customers with an unmatched global cold chain solution under one company”, said Tom Anderson, CEO of MTS.
Anderson continued, “We’re confident that together we’ll deliver products and services to the industry better than any competitive offering. An accelerated product development programme which will significantly enhance the combined company’s solution set and associated cold chain services is already underway.”
Algorithm Predicts Life Expectancy After Heart AttackNews
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.
Plug-and-Play Diagnostic Devices DevelopedNews
Researchers at MIT’s Little Devices Lab have developed a set of modular blocks that can be put together in different ways to produce diagnostic devices. These “plug-and-play” devices, which require little expertise to assemble, can test blood glucose levels in diabetic patients or detect viral infection, among other functions.READ MORE